| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 07/08/2008 | US7396652 Chemokine PANEC-2 polypeptides and compositions and methods related thereto |
| 07/08/2008 | US7396546 Anti-microbial compositions and methods of using same |
| 07/08/2008 | US7396530 by integrin (anti-CD11a antibody/efalizumab) antagonist; synergistic with cyclosporine, isotretinoin, etretinate, corticosteroids, fumaric acid esters, dapsone, niacinamide, low-dose chlorambucil, clofazimine or immunosuppressive agent; side effect reduction, rapid improvement |
| 07/08/2008 | CA2445620C Tetracyclic compounds as pde5-inhibitors |
| 07/08/2008 | CA2438596C Tetrahydro-pyrazino (1,2-a) indoles for the treatment of central nervous disorders |
| 07/08/2008 | CA2432131C Pyrazole compounds useful as protein kinase inhibitors |
| 07/08/2008 | CA2395077C Liquid composition of biodegradable block copolymer for drug delivery system and process for the preparation thereof |
| 07/08/2008 | CA2387134C Cyclopropanes as cgrp antagonists, medicaments containing said compounds and method for the production thereof |
| 07/08/2008 | CA2330719C Synergistic compositions comprising an ascorbate and lysine for states related to extra cellular matrix degeneration |
| 07/08/2008 | CA2271268C Therapeutic and cosmetic compositions comprising an extract of crude shark liver oil, their use and method for the preparation thereof |
| 07/08/2008 | CA2200324C 4a-aryldecahydroisoquinoline compounds and medicinal use of the same |
| 07/08/2008 | CA2198706C Methods for the treatment of inflammatory joint disease |
| 07/03/2008 | WO2008080015A2 Compounds and methods for kinase modulation, and indications therefor |
| 07/03/2008 | WO2008080001A2 Compounds and methods for kinase modulation, and indications therefor |
| 07/03/2008 | WO2008079933A2 Heteroaryl-heteroaryl compounds as cdk inhibitors for the treatment of cancer, inflammation and viral infections |
| 07/03/2008 | WO2008079857A1 Crystalline forms of aryl-substituted pyrazole-amide compounds |
| 07/03/2008 | WO2008079720A1 Alpha-2b receptor agonist and anticonvulsant compositions for treatng chronic pain |
| 07/03/2008 | WO2008079687A1 Novel compounds as cannabinoid receptor ligands and uses thereof |
| 07/03/2008 | WO2008079371A1 Modulators of c3a receptor and methods of use thereof |
| 07/03/2008 | WO2008079346A1 5-cyan0-4- (pyrrolo [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors |
| 07/03/2008 | WO2008079293A1 Pyrrolo [3, 2-a] pyridine derivatives for inhibiting ksp kinesin activity |
| 07/03/2008 | WO2008079292A1 Heterocyclic compounds and their use in treating inflammation, angiogenesis and cancer |
| 07/03/2008 | WO2008079279A1 Heterocyclic compounds with cxcr3 antagonist activity |
| 07/03/2008 | WO2008079073A1 Indazolyl sulphonamide derivatives for the treatment of glucocorticoid receptor mediated disorders |
| 07/03/2008 | WO2008078730A1 Preparation for transnasal application |
| 07/03/2008 | WO2008078715A1 Therapeutic agent for inflammatory myopathy containing il-6 antagonist as active ingredient |
| 07/03/2008 | WO2008078411A1 Pharmaceutical agent for prevention and/or treatment of inflammatory myopathy |
| 07/03/2008 | WO2008078249A1 Anti-inflammatory agents |
| 07/03/2008 | WO2008077404A1 Substituted acetophenones useful as pde4 inhibitors |
| 07/03/2008 | WO2008077277A1 Process for preparation of spider lyophilizate and use in medicaments and functional foods |
| 07/03/2008 | WO2008077276A1 An injectable solution of spider venom and preparation thereof |
| 07/03/2008 | WO2008077194A1 Receptor agonists |
| 07/03/2008 | WO2008057511A3 Ascomycin and pimecrolimus having reduced levels of desmethylascomycin and 32-deoxy-32-epichloro-desmethylascomycin respectively, and methods for preparation thereof |
| 07/03/2008 | WO2008054594A3 Method for controlling angiogenesis in animals |
| 07/03/2008 | WO2008024980A3 Pyrrole, thiophene, furan, imidazole, oxazole, and thiazole derivatives |
| 07/03/2008 | WO2006134494A3 Anti-connexin compounds and therapeutic uses thereof |
| 07/03/2008 | US20080161907 Stent coated with a sustained-release drug delivery and method for use thereof |
| 07/03/2008 | US20080161562 2-(6-Chloro-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl)-benzonitrile |
| 07/03/2008 | US20080161426 p53 Inhibitors and Therapeutic Use of the Same |
| 07/03/2008 | US20080161364 Enteric Medicinal Composition For Oral Use |
| 07/03/2008 | US20080161351 Peroxisome proliferator-activated receptor (PPAR) delta modulators; inhibitors of inducible nitric oxide synthase (iNOS) or tumor necrosis factor (TNF); metabolic disorders, inflammatory diseases and cancer |
| 07/03/2008 | US20080161348 Use of pitavastatin or salt thereof to treat rheumatoid arthritis |
| 07/03/2008 | US20080161346 Pyridines or pyrimidines having 4-(hydrogenated 1-pyridyl- or hydrogenated 1-isoquinolyl rings, e.g., N-(4-chlorophenyl)-2-(pyridin-4-ylmethyl)-1,2,3,4-tetrahydroisoquinoline-5-carboxamide; kinase inhibitors; inflammation, angiogenesis and cancer |
| 07/03/2008 | US20080161334 Macrolides |
| 07/03/2008 | US20080161329 Pharmaceutical uses |
| 07/03/2008 | US20080161310 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
| 07/03/2008 | US20080161303 Imidazo- and triazolo-pyridine compounds and methods of use thereof |
| 07/03/2008 | US20080161287 Bicyclic compound, production and use thereof |
| 07/03/2008 | US20080161275 Compositions and methods for the treatment of inflammatory disease |
| 07/03/2008 | US20080161259 Complementary to a target nucleotide sequence; reduces the expression and/or function of the target nucleotide sequence; antiinflammatory |
| 07/03/2008 | US20080161257 Oligonucleotide-Containing Pharmacological Compositions And Their Use |
| 07/03/2008 | US20080161248 Methods and Compositions for Therapeutic Treatment |
| 07/03/2008 | US20080160576 Anti-alphabeta3 humanized monoclonal antibodies |
| 07/03/2008 | US20080160082 Controlled release compositions comprising Nimesulide |
| 07/03/2008 | US20080160074 three-dimensional synthetic and semi-synthetic compositions having biological activity, such as liposomes, beads or similar particles; anti-inflammatory, organ protective and immune regulatory effects |
| 07/03/2008 | US20080160054 vectors or transgenic organisms; biosynthesis; derived from Physcomitrella |
| 07/03/2008 | US20080160041 C-type lectin specific monoclonal antibody conjugate for use in reducing immune response to specific antigens; immunotherapy; immunosuppression; treating allergies and autoimmune diseases |
| 07/03/2008 | US20080160022 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules |
| 07/03/2008 | US20080160018 Using mik- beta 1 monoclonal antibody as therapeutic tool in treatment and prevention of graft vs. host, autoimmune and diabetic disorders |
| 07/03/2008 | US20080160005 Interleukin-6 suppressive agent |
| 07/03/2008 | US20080159959 antiinflammatory agents has water-soluble N-(2-hydroxypropyl) methacrylamide copolymer linked to a glucocorticoid; drug conjugated with a polymer for targeting to bone or cartilage tissue; treatment of rheumatoid arthritis using MR imaging techniques |
| 07/03/2008 | CA2790018A1 Formulations |
| 07/03/2008 | CA2673736A1 Compounds and methods for kinase modulation, and indications therefor |
| 07/03/2008 | CA2673606A1 Alpha-2b receptor agonist and anticonvulsant compositions for treatng chronic pain |
| 07/03/2008 | CA2673472A1 5-cyan0-4- (pyrrolo) [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors |
| 07/03/2008 | CA2673410A1 Pyrrolo [3, 2-a] pyridine derivatives for inhibiting ksp kinesin activity |
| 07/03/2008 | CA2673370A1 Substituted acetophenones useful as pde4 inhibitors |
| 07/03/2008 | CA2673231A1 Heterocyclic compounds with cxcr3 antagonist activity |
| 07/03/2008 | CA2672916A1 Cd44 antibodies |
| 07/03/2008 | CA2672518A1 Organic compounds and their uses |
| 07/03/2008 | CA2671766A1 Modulators of c3a receptor and methods of use thereof |
| 07/02/2008 | EP1939300A1 Methods and compositions for lowering the level of tumor necrosis factor (TNF) in TNF-associated disorders |
| 07/02/2008 | EP1939295A1 Vaccine compostions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 07/02/2008 | EP1939291A2 Inhibitor oligonucleotides and their use for specific repression of a gene |
| 07/02/2008 | EP1939203A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta isoform |
| 07/02/2008 | EP1939173A1 O-substituted-dibenzyl urea- or thiourea- derivatives as trpv1 receptor antagonists |
| 07/02/2008 | EP1938827A1 Novel inhibitor of vascular endothelial growth factor expression |
| 07/02/2008 | EP1938824A1 Medicine, food and drink or feed containing sphingomyelin |
| 07/02/2008 | EP1938820A1 Liquid preparation for external application containing indomethacin |
| 07/02/2008 | EP1938809A1 Adhesive skin patch |
| 07/02/2008 | EP1937685A1 Tetrahydro-pyrrolizinone compounds as lfa-i mediators |
| 07/02/2008 | EP1937681A1 5-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of c-fms kinase |
| 07/02/2008 | EP1937666A1 Substituted heterocyclic compounds with cxcr3 antagonist activity |
| 07/02/2008 | EP1937650A1 Heterocyclic compounds |
| 07/02/2008 | EP1937645A1 Pyrazoles useful in the treatment of inflammation |
| 07/02/2008 | EP1937643A2 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof |
| 07/02/2008 | EP1937641A2 Dihydro-[1h]-quinolin-2-one derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes |
| 07/02/2008 | EP1937640A2 1,2,3,5-tetrahydro-cyclopental[c]quinolin-4-one derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes |
| 07/02/2008 | EP1937250A2 Ligustilide derivatives for the treatment of inflammatory disorders |
| 07/02/2008 | EP1937238A1 Novel nitrocatechol derivatives having selectin ligand activity |
| 07/02/2008 | EP1825861A4 Anti-inflammatory extract and agent and method for the production thereof |
| 07/02/2008 | EP1633702B1 Protease inhibitors |
| 07/02/2008 | EP1501808B1 Tachykinin receptor antagonists |
| 07/02/2008 | EP1474425B9 Deazapurines and uses thereof |
| 07/02/2008 | EP1471916B1 Treatment of rheumatoid arthritis using imatinib |
| 07/02/2008 | EP1459762B1 Use of emp9 for the prevention of proliferative organ diseases |
| 07/02/2008 | EP1296940B1 Amidine derivatives as selective antagonists of nmda receptors |
| 07/02/2008 | EP1165057B1 Endodontic fibers and methods of use therefor |
| 07/02/2008 | EP1115720B1 Novel n-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them |
| 07/02/2008 | CN101213195A Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect |